Swiss company with expertise in plasma medicine

By developing and manufacturing innovative, easily manageable cold plasma therapy pens, the ActivCell Group is promoting the establishment of plasma medicine as an efficient treatment method in everyday medical practice. In cooperation with renowned European technology institutes and universities, ActivCell Group AG is making an important contribution to the research and ongoing development of this future-focused form of therapy in human and veterinary medicine.

The ActivCell-team

Andrea Preuss, <b>PhD</b>

Andrea Preuss, PhD

Head of Medical Division
Member of the Executive Board
Michael Hiestand, <b>Dr med vet</b>

Michael Hiestand, Dr med vet

Head of Veterinary Division
Member of the Executive Board
Thomas Fünfschilling, <b>Dipl Ing ETH </b>

Thomas Fünfschilling, Dipl Ing ETH

Head of R&D
Stephan Gregorini, <b>PhD</b>

Stephan Gregorini, PhD

Senior Manager, Regulatory Affairs & Quality Management
Urs Laubscher

Urs Laubscher

Advisor R&D and Production Technology
Daniele Scarabello

Daniele Scarabello

Manager, Finance & Administration
Selina Keller, <b>Dr med vet</b>

Selina Keller, Dr med vet

Product and Sales Manager, Veterinary Division
Linda Kardache

Linda Kardache

Business Development and Key Account Manager, Veterinary Division
Milana Becic

Milana Becic

Administration of the Lenzburg office

Board of Directors

Ruedi Weber

Ruedi Weber

Founder and President of the Board of Directors
Former Founder and Managing Director SIA/SWB, previously Ruedi Weber + Architekten und Planer AG
Peter Weber

Peter Weber

Founder and Member of the Board of Directors
President of the Board of Directors peka-metall AG
Peter Frei, <b>Dipl Ing FH</b>

Peter Frei, Dipl Ing FH

Founder and Member of the Board of Directors
Manager and Owner IQF LLC
Dominik Lysek, <b>PhD</b>

Dominik Lysek, PhD

Member of the Board of Directors
Partner Let’s Innovate

Veterinary Advisory Board

Verena Denise Bracher

Verena Denise Bracher

Dr med vet
Claudia Nett

Claudia Nett

Dr med vet, DipACVD, EBVS
Adrian Steiner

Adrian Steiner

Prof Dr med vet, FVH, ECVS, ECBHM
Heinz W. Burkhardt

Heinz W. Burkhardt

Dr med vet, FVH
Michael Hiestand

Michael Hiestand

Dr med vet

Careers at ActivCell Group AG

The ActivCell Group is a dynamic start-up company. We develop, produce and distribute innovative mobile cold plasma therapy devices in the form of handy pens.

Positions to be filled:

No vacancies at the moment

Unfortunately, we do not have any vacancies at the moment. However, we are always happy to receive unsolicited applications.

The history of the ActivCell Group

The motivation for founding ActivCell arose from the founders’ own experience with illness. Brothers Peter and Ruedi Weber struggled with ailments that were difficult to treat and did not respond to conventional therapies. In their search for alternatives, they came across high-frequency electrotherapy and experienced impressive healing successes.

Convinced that this therapy should have a more significant place in the medical world, Peter and Ruedi Weber decided to have the technology and its mechanisms of action researched and transferred into practice. At that time, there were no handy, mobile devices approved for medical use on the market for this form of therapy.

Determined to change this situation, Ruedi and Peter Weber founded ActivCell AG in 2014 together with Swiss engineers and scientists from the fields of medical technology and industrial design. The first handy, cordless prototypes for veterinary medicine were quickly developed.

The fact that these devices were also excellent sources of cold plasma and promised great benefits for the emerging field of plasma medicine gave clear direction to the disciplines of research and development for both veterinary and human medicine.

In 2017, the company launched its first devices for veterinary medicine. The devices were further developed according to market requirements and relaunched in 2020.

In the same year, ActivCell AG was renamed ActivCell Group AG and started the approval process for the use of the ActivCellpen in human medicine.